NCT04527432View on ClinicalTrials.gov

COVID-19 Health Professional Impact Study

NACompletedINTERVENTIONAL
Enrollment

1,504

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

October 27, 2023

Study Completion Date

October 27, 2023

Conditions
Coronavirus InfectionSevere Acute Respiratory Syndrome
Interventions
OTHER

Survey

Survey at baseline, 6 and 12 months

DIAGNOSTIC_TEST

SARS-CoV-2 antibody test

SARS-CoV-2 antibody test results and testing again at 6 and 12 months

Trial Locations (1)

WV10 0QP

The Royal Wolverhampton NHS Trust, Wolverhampton

All Listed Sponsors
collaborator

University of Wolverhampton

OTHER

lead

The Royal Wolverhampton Hospitals NHS Trust

OTHER_GOV

NCT04527432 - COVID-19 Health Professional Impact Study | Biotech Hunter | Biotech Hunter